Geneos Wealth Management’s Corelogic, Inc. CLGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-400
Closed -$26K 3043
2020
Q3
$26K Hold
400
﹤0.01% 1540
2020
Q2
$27K Hold
400
﹤0.01% 1500
2020
Q1
$13K Hold
400
﹤0.01% 1709
2019
Q4
$17K Hold
400
﹤0.01% 1773
2019
Q3
$18K Hold
400
﹤0.01% 1670
2019
Q2
$16K Hold
400
﹤0.01% 1753
2019
Q1
$14K Hold
400
﹤0.01% 1732
2018
Q4
$13K Hold
400
﹤0.01% 1709
2018
Q3
$19K Hold
400
﹤0.01% 1609
2018
Q2
$20K Hold
400
﹤0.01% 1459
2018
Q1
$18K Hold
400
﹤0.01% 1443
2017
Q4
$18K Hold
400
﹤0.01% 1437
2017
Q3
$18K Hold
400
﹤0.01% 1379
2017
Q2
$17K Hold
400
﹤0.01% 1353
2017
Q1
$16K Sell
400
-12
-3% -$455 ﹤0.01% 1338
2016
Q4
$15K Hold
412
﹤0.01% 1317
2016
Q3
$16K Buy
412
+12
+3% +$478 ﹤0.01% 1226
2016
Q2
$15K Hold
400
﹤0.01% 1214
2016
Q1
$13K Buy
+400
New +$13.6K ﹤0.01% 1238

Other funds holding CLGX

Geneos Wealth Management's CLGX Position: Q4 2020 in Review

Geneos Wealth Management sold out of Corelogic, Inc. (CLGX) in Q4 2020, closing a stake of 400 shares — an estimated $26K sold.

Geneos Wealth Management first reported a position in CLGX in Q1 2016 and held it in 19 quarters. The position peaked at $27K in Q2 2020. 323 funds tracked by Wall St. Rank hold CLGX as of Q4 2020.

  • Geneos Wealth Management reported no remaining Corelogic, Inc. position as of Q4 2020 after selling out during the quarter.
  • Geneos Wealth Management sold 400 Corelogic, Inc. shares in Q4 2020, an estimated $26K.
  • Geneos Wealth Management first reported a position in Corelogic, Inc. in Q1 2016 and held it in 19 quarters.
  • Geneos Wealth Management's Corelogic, Inc. position peaked at $27K in Q2 2020.
  • 323 funds tracked by Wall St. Rank held Corelogic, Inc. as of Q4 2020.

Based on Geneos Wealth Management's 13F filing for Q4 2020, filed 19 May 2021.